Moderna and Merck expand partnership to develop new cancer vaccinesModerna and Merck & Co have expanded their partnership to develop and commercialise novel personalised messenger RNA (mRNA) Share XModerna and Merck expand partnership to develop new cancer vaccineshttps://pharmaphorum.com/news/moderna-and-merck-expand-partnership-to-develop-new-cancer-vaccines/
Scancell to collaborate with charity CRUK on cancer vaccineTrial will combine cancer vaccine with checkpoint inhibitor Share XScancell to collaborate with charity CRUK on cancer vaccinehttps://pharmaphorum.com/news/scancells-cancer-vaccine-enters-clinic-deal-cruk/
Lilly joins cancer vaccine race with CureVac allianceLilly has signed a deal with CureVac to develop up to five next-generation cancer vaccines which use messenger Share XLilly joins cancer vaccine race with CureVac alliancehttps://pharmaphorum.com/news/lilly-joins-cancer-vaccine-race-curevac-alliance/
Dendreon files for bankruptcy as Provenge faltersDespite its best efforts to streamline and transform itself into a good buy for prospective purchasers, biotech Dendreon Share XDendreon files for bankruptcy as Provenge faltershttps://pharmaphorum.com/news/dendreon-files-for-bankruptcy-as-provenge-falters/